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Abstract
Background: Dengue has become a major concern for international public health. Frequent epidemic outbreaks are
believed to be driven by a complex interplay of immunological interactions between its four co-circulating serotypes and
large fluctuations in mosquito densities. Viral lineage replacement events, caused for example by different levels of cross-
protection or differences in viral fitness, have also been linked to a temporary change in dengue epidemiology. A major
replacement event was recently described for South-East Asia where the Asian-1 genotype of dengue serotype 2 replaced
the resident Asian/American type. Although this was proposed to be due to increased viral fitness in terms of enhanced
human-to-mosquito transmission, no major change in dengue epidemiology could be observed.
Methods/Results: Here we investigate the invasion dynamics of a novel, advantageous dengue genotype within a model
system and determine the factors influencing the success and rate of fixation as well as their epidemiological consequences.
We find that while viral fitness overall correlates with invasion success and competitive exclusion of the resident genotype,
the epidemiological landscape plays a more significant role for successful emergence. Novel genotypes can thus face high
risks of stochastic extinction despite their fitness advantage if they get introduced during episodes of high dengue
prevalence, especially with respect to that particular serotype.
Conclusion: The rarity of markers for positive selection has often been explained by strong purifying selection whereby the
constraints imposed by dengue’s two-host cycle are expected to result in a high rate of deleterious mutations. Our results
demonstrate that even highly beneficial mutants are under severe threat of extinction, which would suggest that apart from
purifying selection, stochastic effects and genetic drift beyond seasonal bottlenecks are equally important in shaping
dengue’s viral ecology and evolution.
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Introduction
Dengue virus (DENV) is the most wide-spread arbovirus
affecting human populations. During the last decades it has
increasingly become a major public health problem with
significant economic and social impact [1–3]. It is transmitted
between humans in urban and peri-urban settings predominantly
by the Aedes aegypti and Aedes albopictus mosquitoes vector [4]. Ae.
aegypti is extremely well adapted to urban environments where it
efficiently breeds in artificial water containers, such as flower pots,
plastic bags or discarded car tires, near human habitations. Both
vectors have undergone rapid expansion worldwide in the last
couple of decades leading to DENV endemicity in more than 100
countries [5].
There are four closely related and potentially co-circulating
serotypes of DENV (DENV1-DENV4) [6,7] and recovery from
infection is believed to provide life-long immunity to the infecting
serotype but only a brief period of heterologous protection to all
other serotypes [8]. Most primary infections are self-limited and
clinically silent but can occasionally result in a short-lived febrile
illness which is commonly known as dengue fever (DF). In some
cases this may progress to more severe and life-threatening illness
such as dengue haemorrhagic fever (DHF) or dengue shock
syndrome (DSS) [9]. While several risk factors for developing
DHF/DSS have been described, including host genetic back-
ground, viral genotype, order of infecting serotype, time between
infections or age of infection [1,9], the most widely cited
explanation is that of Antibody Dependent Enhancement (ADE)
(e.g. [10–13]) whereby subneutralizing antibodies from primary
infection can mediate viral entry into host cells leading to
increased replication and disease manifestations [14–18].
The temporal epidemiological pattern of dengue is character-
ized by semi-periodic outbreaks whilst the inter-epidemic cycles in
DF/DHF incidence highly correlate with the seasonal variations in
vector population size (see e.g. [19]). Furthermore, individual
serotype prevalences show cyclical replacements in dominance
(Figure 1A) which are believed to be induced by the immune
profile of the human population [20,21].
Phylogenetic studies based on complete sequences of structural
genes of all 4 serotypes have demonstrated the existence of
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multiple lineages in which different genotypes can be clustered
[6,7]. Despite a general bias in the literature towards studies based
on single-gene approaches, spatio-temporal patterns of genotype
replacement in endemic regions have been widely recovered from
data [6,7,22–24]. With the extrinsic pressures on DENV, such as
seasonal or human-forced reductions in vector population size or
abundance and mobility of susceptible hosts, it has been proposed
that genetic drift plays a major role in the observed phylodynamics
[22,25]. Furthermore, most studies have reported that DENV
recent molecular evolution is marked by strong purifying selection,
possibly due to the requirement of its two-host life cycle, and few
reports have been able to show convincing evidence for positive
selection either by the existence of non-synonymous mutations or
in measures of fitness advantage in viral traits [6,7,23,24,26].
Following earlier reports of inter-serotypic difference in virulence
(see e.g. [27]) one of the first convincing evidences for genetic
determinants in disease outcome came from epidemiological studies
suggesting that the DENV2 Asian genotype was associated with
higher frequencies in DHF compared to the American genotype
[28]. In vitro studies have since shown that the replication rate in
both human monocyte-derived macrophages and dendritic cells as
well as the vector’s susceptibility were higher for the Asian genotype
[29,30]. It was also found that the Asian genotype of DENV2 had a
slightly higher replication rate within the mosquito and a shorter
extrinsic incubation period [31]. These results provided a rational
explanation for the replacement patterns observed in the Americas,
where displacement of the American genotype by the Asian
genotype has taken place in several countries in recent years
[28,29,32]. A similar lineage replacement event has also occurred in
SE Asia, with Asian-1 lineage viruses having displaced Asian/
American viruses from Viet Nam (Figure 1B), Cambodia and
Thailand. This displacement was proposed to be due to difference
in in vivo fitness, with higher viraemia levels observed in Asian-1
infected patients that could lead to an enhanced probability of
human-to-mosquito transmission [33].
The study by Hang et al. [33] demonstrated some other
intriguing aspects about the invasion dynamics of Asian-1. A
phylogenetic analysis suggested that the Asian genotype was
introduced into the population years before it had been detected,
and once it was detected it reached fixation within a relatively
short period of time. The rate at which this genotype replaced the
Asian/American type would suggest a significant fitness advantage
not only over the resident genotype but possibly also over the other
circulating serotypes; however, there was no discernible difference
in the overall epidemiological dynamics in the period before or
after fixation. Although these results suggested that a fitness
advantage in a specific viral trait played a decisive role, the
emergence of advantageous genotypes are as likely to be driven by
the level of transmission and the underlying immune status of the
human population.
Here we have constructed an epidemiological model of dengue
to qualitatively address the impact of immunity and transmission
on the invasion and replacement patterns of a novel advantageous
dengue genotype. Our results suggest that the observed replace-
ment events can be explained by competition between genotypes
of relatively small fitness differences which, although sufficient for
displacement, do not interfere with the overall serotype dynamics.
Furthermore, we show that invasion success and total time
required for fixation are strongly influenced by inter- and intra-
serotype competition at the time of introduction.
Methods
Description of the model
The model is an extension of the 4-serotype mathematical
framework analysed by Recker et al. [34] and includes a mosquito
vector component, temporary cross-immunity after primary
infection and seasonal forcing in mosquito biting. In summary,
we disregard the effect of maternal antibodies and instead assume
that human individuals are born susceptible to all 4 serotypes.
After recovery from primary infection they acquire life-long
immunity to the infecting serotype and cross-immunity to any
other serotype for a short period of time. As temporary immunity
wanes, individuals become susceptible to secondary heterologous
infection. For simplicity and because of the relative rarity of
reported third and fourth infections we assume that after recovery
from secondary infections individuals remain fully protected
against further challenges [4,35]. The system can then be given
by the following set of differential equations describing the rate of
change in humans either susceptible, infected with, temporarily
immune or recovered from dengue serotypes i, i~DENV1,
DENV2, DENV29, DENV3 or DENV4:
dS
dt
~mNh{
X
i
lvizm
 !
S ð1Þ
dIi
dt
~lvi S{(sizm)Ii ð2Þ
dXi
dt
~siIi{(azm)Xi ð3Þ
dRi
dt
~aXi{
X
j=i
clvjzm
 !
Ri ð4Þ
dIji
dt
~clvi Rj{(sizm)Iji ð5Þ
Author Summary
Dengue fever and the more severe dengue haemorrhagic
fever and dengue shock syndrome are mosquito borne
viral infections that have seen a major increase in terms of
global distribution and total case numbers over the last
few decades. There are currently four antigenically distinct
and potentially co-circulating dengue serotypes and each
serotype shows substantial genetic diversity, organised
into phylogenetically distinct genotypes or lineages. While
there is some evidence for positive selection, the
evolutionary dynamics of dengue virus (DENV) is supposed
to be mostly dominated by purifying selection due to the
constraints imposed by its two-host life-cycle. Motivated
by a recent genotype replacement event whereby the
resident American/Asian lineage of dengue virus serotype
2 (DENV2) had been displaced by the fitter Asian-1 lineage
we investigated some of the epidemiological factors that
might determine the success and invasion dynamics of a
novel, advantageous dengue genotype. Our results show
that although small differences in viral fitness can explain
the rapid expansion and fixation of novel genotypes, their
fate is ultimately determined by the epidemiological
landscape in which they arise.
Dengue Genotype Replacement
www.plosntds.org 2 November 2010 | Volume 4 | Issue 11 | e894
dR
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~
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with the force of infection of serotype i affecting the human
population, lvi , given as
lvi~gb
v?h
i
I vi
Nv
: ð7Þ
We denote g as the mosquito biting rate and bv?hi as the vector-to-
human transmission probability; 1=si and 1=a are the respective
durations of infection and cross-immunity. Given the short period
of infection we do not account for the possibility of co-infections by
two or more serotypes. We assume a constant human population
size Nh~Sz
P
i (IizXizRiz
P
j Iij)zR and further assume
that infection has a negligible effect on the average death rate, m.
To account for seasonal variation we assume a periodically forced
biting rate, that is we set
g~g0 1zE sin (pt)
k
 
, ð8Þ
where k is a positive integer influencing the ‘seasonality’ where
kw1 results in shorter and more pronounced seasons.
The dynamics of the mosquito population is given as follows:
dSv
dt
~mvNv{
X
i
lhizm
v
 !
Sv ð9Þ
dIvi
dt
~lhi S
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Figure 1. Dengue epidemiology in Southern Viet Nam. (A) The total number of hospitalised cases between 1994–2008 (bars) show the
characteristic fluctuations in disease incidence with a big epidemic outbreak in 1998 followed by years of relatively low disease. The sequential
replacement in dominance of one of dengue’s four co-circulating serotypes (DENV1-DENV4) is clearly visible. (B) In the time between 2002 and 2008
Asian-1 genotype of serotype DENV2 (blue bars) competitively replaced the resident Asian/American type (red bars). Data for 1999 and 2000 missing;
figure reproduced from Hang et al. [33].
doi:10.1371/journal.pntd.0000894.g001
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with the force of infection from humans to mosquitoes given as
lhi~g
bh?vi
Nh
Iiz
X
i
wIji
 !
ð11Þ
In accordance with our previous model [34] we assume that
antibody-dependent enhancement acts to increase both suscepti-
bility to and transmissibility of secondary heterologous infection by
factors c and w, respectively, with values described in Table 1.
To investigate the invasion patterns of a novel and fitter dengue
genotype we assume that DENV2 is represented by two genotypes
which differ in relative fitness but are antigenically equivalent. That
is, individuals previously infected by DENV2 are immune to type
DENV29 and vice versa. We consider four different fitness traits
which we can vary independently: (i) transmissibility from human to
mosquito, e.g. through increased viral load, bh?v2’ , (ii) longer life-
expectancy of mosquitoes infected with DENV29 to emulate a
shorter extrinsic incubation period (EIP), mv2’, (iii) longer infectious
period in humans, 1=s2’, and (iv) an increased level of enhancement
of secondary infections, w’2. These can simply be given using:
bh?v2’ ~b
h?v
2 (1zrb) ð12Þ
mv2’~m
v
2’=(1zrm) ð13Þ
s2’~s2=(1zrs) ð14Þ
w2’~w2(1zrw) ð15Þ
That is, ri, can be considered as the degree of the fitness advantage.
In line with the suggestion by Hang et al. [33], most of our analysis is
concentrated on the fitness advantage due to increased viral load
and thus transmissibility from the infected human individual to the
mosquito vector, bh?v2’ . In fact, we found that the results presented
here are invariant to the actual viral trait that is enhanced; results
obtained under changes to other viral traits can be found in the
supporting material.
Stochastic simulations
To address certain aspects of the invasion process of a more
probabilistic nature, such as invasion success rates and fixation
events, we also implemented the above model as a stochastic
framework using a tau-leap Gillespie algorithm [36]. Stochastic
simulations were initialized with equilibrium population status
derived from the deterministic framework with parameter values
the same as given in Table 1 (see Figure S7 and S8 for general
model behaviour).
Results
We used a simple epidemiological model of dengue to
investigate the effect of host population immunity structures and
transmission settings on the invasion pattern of a novel DENV2
genotype, hereby denoted as DENV29. The model is based on a
previously introduced deterministic, multi-serotype framework
(e.g. [34,37,38]) but extended to include the mosquito vector
population, with seasonal fluctuations in biting frequencies, and a
period of temporary cross-immunity; full model details are given in
the Methods section. We verified our model predictions within a
stochastic framework which allowed us to more adequately address
and further explore certain aspects of the invasion and replace-
ment dynamics and their determinants [39].
The general dynamics generated by our model under parameter
values given in Table 1 and prior to the introduction of a novel
DENV2 genotype are characterised by semi-regular epidemic
outbreaks and asynchronous cyclical behaviour in serotype
prevalence (Figure 2). In accordance with previous studies (e.g.
[34,37,40]) a wide range of incidence and serotype dynamics with
different inter-epidemic periods can also be found under changes
to key parameters values, especially those relating to the degree of
enhancement of secondary infection or the period of temporary
cross-immunity (Figures S1 and S2). For the remainder of this
work, however, we kept most parameter values constant to allow
for better comparisons between invasion patterns and their
epidemiological determinants.
Genotype invasion and replacement
We examined the dynamics of a novel genotype introduced into a
dengue endemic population by either an infected human individual
or via an infected mosquito. The novel genotype is here denoted as
DENV29, to represent the Asian-1 genotype of serotype 2, whereas
the resident type is denoted as DENV2 to represent the Asian/
Table 1. Model Parameters.
parameter definition value
m host lifespan 70 years
a temporary heterologous immunity 5 months
s infectious period 3.65 days
c susceptibility enhancement 1.33
w transmissibility enhancement 1.66
rb increase in probability of human-to-
mosquito transmission
0ƒrbƒ1
rs increase in infectious period 0ƒrsƒ1
rw increase in enhancement of
secondary infections
0ƒrwƒ1
Nh host population size 9 million
Nv vectore population size 22.5 million
mv vector lifespan 16 days
E amplitude in seasonality 0.3
g0 biting rate 115 per year
bh?v transmission probability
human?mosquito
0.9
bv?h transmission probability
mosquito?human
0.8
k speed in seasonality change 2
detection threshold
(relative frequency)
10%
deterministic fixation threshold
(relative frequency)
99%
deterministic number of
introduced DENV29 (cases)
1 infected
mosquito
stochastic fixation threshold (cases) 0
stochastic number of introduced
DENV29 (cases)
2 per infectious
class
Parameter values used in the deterministic and stochastic simulations.
doi:10.1371/journal.pntd.0000894.t001
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American type. Figure 3 shows the result of an invasion scenario
where the invading genotype has a small fitness advantage over the
resident type (rb~0:045, corresponding to a fitness advantage of
4:5%). In this case, higher viral fitness was realised through
enhanced transmissibility from infected human individuals to the
mosquito vectors, i.e. bh?v2’ wb
h?v
2 . In agreement with the data, two
important features of the invasion dynamics can be observed and
are highlighted in Figure 3B. Despite the eventual fast rate at which
the advantageous genotype replaces the resident type, there is a
significant lag between the point of introduction and the time when
DENV29 genotype would reach a detectable level of prevalence
within the population; we refer to this level of prevalence as
detection threshold. Furthermore, despite the expected temporary
rise in dengue incidence, compared to the situation without
invasion, the overall dynamics in both disease incidence and
serotype prevalence remain largely invariant (Figure 3A). This
suggests that both the time lag between introduction and first
detection and also the rapid exclusion of the resident genotype, such
as reported by Hang et al. [33], can be explained by a relatively small
fitness advantage of the invading genotype.
The same qualitative behaviour can be also found when
changing other viral traits which could determine the fitness
advantage. That is, shortening the extrinsic incubation period, rm,
increasing the duration of infection, rs, or the level of
enhancement of secondary infection, rw, have the same effect as
increasing the transmission probability from infected humans to
mosquitoes, rb. Notably, though, when considering low advan-
tages, smaller differences in terms of viral fitness are required to
achieve the same rate of fixation if the fitness advantage manifests
itself in longer infectious periods compared to an increase in
transmissibility (Figure S3). Interestingly, while similar levels of
fitness advantages in either EIP or transmissibility result in the
same fixation times (Figure S4), the disturbance on the
epidemiological pattern of dengue is less severe when the fitness
advantage is expressed in the mosquito (Figure S5). From now on,
we concentrate only on a fitness advantage through the proposed
increase in human-to-vector transmission.
The effect of viral fitness and time of introduction
As shown in Figure 3, a small increase in transmissibility from
human to mosquito seems sufficient for a novel genotype to
displace a resident type within a short period of time. The actual
rate of competitive exclusion and overall time from introduction of
the advantageous genotype to its fixation in the population is likely
to depend on various factors including fitness advantage, rate of
transmission and immune profile within the human population. As
shown in Figure 4A, increasing viral fitness accelerates the rate at
which the invading genotype drives the resident type, DENV2, to
extinction, resulting in a shorter period between introduction and
fixation. For example, increasing the fitness advantage from 8% to
28% reduces the time to fixation from &8 years down to &2
years. However, this increase in viral fitness has a major effect on
dengue incidence patterns and the dynamics of the other
serotypes. In this case it leads to a significantly bigger epidemic
outbreak at the time of replacement followed by a long period of
low transmission and low prevalence of serotype 2 which could
endanger its continuous persistence; this is highlighted in Figure 4B
(compare to Figure 3A).
We next addressed the effect of the time of introduction on the
invasion dynamics. This was simply motivated by the fact that
serotype competition is not constant over time but is strongly
affected by the level of transmission which itself is dependent on
host immunity level and seasonal variation in mosquito densities.
Not surprisingly, we found that the time of introduction can
significantly alter the time taken for a novel genotype to reach
fixation. Figure 5A shows the decrease in the frequency of
DENV2, relative to the fitter genotype DENV29, for two different
time points of introduction. However, while the overall duration
from invasion to fixation is dependent on the time when DENV29
gets introduced, the actual rate of replacement remains constant.
In other words, the time taken from DENV29 passing a detection
threshold, relative to DENV2, to reaching fixation is independent
of the time of introduction (Figure 5B) and therefore independent
of the overall epidemiological dynamics. This, on the other hand,
suggests that the time lag between introduction and the point
when it has spread sufficiently for detection, or waiting time, is
strongly influenced by the epidemiological profile at that time.
To investigate further the determinants for fixation time we
simulated a number of invasion events at various time points over
a four year period and recorded the total time to fixation for each
event with respect to (i) the number of naive individuals, (ii)
serotype 2 susceptible individuals, (iii) disease prevalence and (iv)
mosquito biting frequency. While we could not find a clear
correlation between any of these population profiles and fixation
Figure 2. General model behaviour. Under parameter values given in Table 1 the model reproduces the typical epidemiological pattern of dengue,
showing the cyclical behaviour in serotype prevalence (coloured lines) and semi-regular epidemic outbreaks (total incidence per month, grey line).
doi:10.1371/journal.pntd.0000894.g002
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time, we observed a trend for longer fixation times during the time
window where the relative prevalence of serotype 2 was increasing
(Figure S6).
The effect of serotype competition on emergence time
and invasion success
The results from our deterministic model suggest that novel
genotypes can face long periods at very low prevalence before
breaching a detection threshold and going to fixation. Within a
more realistic setting these periods signify an enhanced risk of
stochastic extinction of the novel type despite its fitness advantage
over the resident type. To better address the invasion success of
DENV29 we used a stochastic formulation of our model (see
Methods) and simulated a number of invasion events over a period
of four years and recorded the success rate of invasion, here
defined as the successful introduction into a population followed
by competitive exclusion of the resident type. As demonstrated in
Figure 6A we observed that invasion success shows an oscillatory
behaviour whose phase seems negatively correlated to total dengue
prevalence at time of introduction. This suggests that the invasion
of a newly advantageous genotype can be hampered by serotype
competition during epidemics and favoured during off-season
periods. Moreover, the amplitude of oscillation, i.e. the maximum
success rate, is dependent on and again negatively correlated to
serotype 2 prevalence. Figure 6B shows the increase in relative
prevalence of DENV2 over the 4-year period which clearly
correlates with a decline in the success rate of DENV29.
Since the time taken from passing a detection threshold to
reaching fixation was shown to be independent of the time of
introduction (Figure 5B), we focused on the relationship between
serotype 2 prevalence and the time to emergence, i.e. the period
between introduction and reaching a 10% prevalence threshold.
Figure 7 clearly illustrates that a novel and advantageous genotype
entering the population during periods of high DENV2 prevalence
will face significantly longer emergence times than those introduced
during periods of low prevalence. Together our results indicate that
Figure 3. Dynamics of an invading genotype. (A) Plotting the frequency of DENV29 relative to DENV2 highlights two phases of the invasion
process: a period of very low frequency and a subsequent rapid shift in dominance and competitive exclusion. The fitness advantage in both plots is
due to increased human-to-vector transmission rate (rb~0:045) over the resident type. (B) The cyclical serotype behaviour remains invariant to the
introduction of a fitter genotype of serotype 2, DENV29 (cyan line), which enters the population at time t~1259:5 (pink arrow) and drives the resident
type, DENV2 (blue line), to extinction after &13 years. Comparing the equivalent time series in Figure 2, no major changes in disease levels or inter-
epidemic period can be observed. Other parameters as in Table 1.
doi:10.1371/journal.pntd.0000894.g003
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the fate of a novel genotype is strongly determined by both inter-
and intra-serotype competition at the time of introduction.
Discussion
We analysed the invasion pattern of a novel dengue genotype
into an endemic population with 4 co-circulating serotypes. Within
our framework we assumed that the invading genotype, repre-
senting the Asian-1 genotype of dengue virus serotype 2, possesses
a fitness advantage over the resident type, the Asian/American
genotype, through enhanced transmissibility from infected human
individuals to the mosquito vectors. This assumption was based on
the findings by Hang et al. [33] which showed increased plasma
viraemia levels in patients infected by Asian-1 DENV2 viruses. In
contrast to other studies [30,41], Hang and colleagues did not find
increased infectivity of Asian-1 viruses to Ae. aegypti mosquitoes per
se; however, it is easy to envisage how higher viral titers could
enhance the ‘per bite’ probability of human-to-vector transmis-
sion. By thus focusing on the hypothesis of a small increase in
transmissibility during primary and secondary infections, and in
agreement with the data, we observed that the total time for
genotype replacement is composed of a period during which the
invading type can circulate at very low prevalence levels for several
years, followed by a rapid shift in dominance and competitive
exclusion after the invading genotype had emerged; here we
defined ‘emergence’ as a threshold level of prevalence where
widespread detection would be highly likely.
Of particular interest is the time lag between introduction and
emergence, or waiting time, when the detection of the new dengue
genotype might be difficult by surveillance systems based on low
viral sampling numbers and/or infrequent genotyping. Not
surprisingly, we found that this period is strongly and positively
affected by the difference in viral fitness between the resident and
novel genotype. In the case of small fitness advantages several
years could pass before the invading type has spread sufficiently to
outcompete the resident type on a population-wide level.
Furthermore, as the epidemiological pattern would remain largely
invariant, passive surveillance systems based simply on case
numbers could also easily fail to detect this intra-serotype
replacement event. These results therefore support the findings
of Hang et al. [33] who hypothesised that a small enhancement of
human-to-mosquito transmission through increased viral load is
Figure 4. The effect of viral fitness on fixation time and epidemiological patterns. (A) The graph demonstrates the increased rate in
competitive exclusion of the resident genotype, DENV2, for increasing levels of viral fitness of the invading type, DENV29, with rb[f0:08,0:18,0:28g.
Higher fitness advantages significantly reduce the period of low level prevalence and the overall time to fixation. (B) Higher fitness advantages, here
rb~0:28, can have a significant effect on both incidence and serotype dynamics, causing a big epidemic outbreak followed by a severe trough in
serotype 2 frequency. Other parameter values as in Table 1.
doi:10.1371/journal.pntd.0000894.g004
Dengue Genotype Replacement
www.plosntds.org 7 November 2010 | Volume 4 | Issue 11 | e894
sufficient to explain the observed invasion pattern in Southern
Viet Nam where Asian-1 was first detected in 2003 despite the
phylogenetic analyses dating the introductory event sometime
during the late 1990’s.
Apart from increased transmission from infected humans to the
mosquito vectors we also considered other viral traits that could be
enhanced in the Asian-1 genotype, such as longer infectious periods
or shorter extrinsic incubation periods (EIP). The latter is of
particular interest as it can potentially lead to a significantly increase
in vectorial capacity [31]. While the actual viral trait which is
enhanced does not alter the overall invasion pattern or results
presented in this work (Figures S3, S4, S5, S9, S10, and S11), we
found that viral fitness traits have an additive effect (Figure S4). This
means that even smaller individual enhancements are sufficient to
explain the observed invasion dynamics of the Asian-1 genotype,
especially under the assumption that this replacement event did not
have a major effect on the sero-epidemiological pattern of dengue.
Interestingly, though, our results suggest that dengue incidence and
serotype dynamics are less disturbed when the fitness advantage is
manifested through shorter EIP than increased infectivity or
transmissibility (Figure S5).
In addition to viral fitness, the time point at which a novel
genotype enters a population is crucially important in determining
its invasion dynamics and ultimately success. Whereas the relative
fitness advantage affects the overall time between introduction and
fixation, the epidemiological profile more strongly determines the
period of low level prevalence before the advantageous genotype
emerges. We tested various epidemiological factors for their
influence on the waiting time but to our surprise only found the
relative prevalence of DENV2 to have a strong effect. That is,
whereas population susceptibility to either dengue in general or
serotype 2 in particular had no immediate influence on the time
between introduction and wide-spread detection, we found that
the relative prevalence of DENV2 at the time of introduction
positively correlates with extended periods during which the novel
genotype circulates below a detection threshold. Therefore, while
transmission intensities strongly affect the success of an invasion
event, the dominance level of serotype 2 within the population
Figure 5. The effect of the time of introduction on the rate of fixation. (A) The graph shows the increase in the frequency of DENV29, relative
to DENV2, for two different time points of introduction (TPI). Despite a discernible difference in the total time for DENV29 to reach fixation and
competitively exclude the resident type, the actual rate of displacement (highlighted as dashed lines) remains the same. That is, the differences in
fixation times in both cases are solely due to the differences in the initial expansion period of the invading genotype before it reaches wide-spread
detection level (here arbitrarily set at 10% relative prevalence). (B) Whereas the relative fitness advantage of the invading genotype has a significant
effect on the rate of replacement, it remains invariant to the time at which it is introduced into the population. All parameters as in Table 1 and
rb~0:045 for (A).
doi:10.1371/journal.pntd.0000894.g005
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determines both the invasion success rate and, independently, the
period before the invading genotype would reach a sufficient level
of prevalence to be widely detecable. Our results thus confirm that
serotype interactions and the resulting epidemiological landscape
can have a big influence on intra-serotype dynamics and thus viral
evolution, as previously noted by Zhang and colleagues [23].
There is considerable interest in determining the evolutionary
processes that underlie the observed structures and genetic
variation of dengue virus populations (both inter- and intra-
serotypic). Overall, low estimates of selection pressure, in terms of
average dN=dS values, and the fact that dengue has a two-host life-
cycle are commonly used to place purifying selection as the
strongest selective force acting on dengue evolution [23,26,42].
However, it is also clear that dengue viruses exhibit strong spatio-
temporal variations. Various phylogenetic studies have identified
frequent DENV lineage turnover events which have resulted in the
characteristic, ladder-like tree (e.g. [24,42]) and which are
commonly ascribed to positive selection [24,32,43]. In addition,
genetic drift has also been proposed to play a major part in dengue
evolution such that the replacement of viral lineages or clades
could be explained through stochastic processes alone. For
example, repeated bottlenecks due to large seasonal fluctuations
in mosquito densities imply that the emergence of novel and
possibly advantageous genotypes could be a recurrent phenome-
non followed by a strong probability for extinction in the
subsequent circulating seasons which could explain the weak
signature for positive selection in the data (compared to purifying
selection). This in turn would also suggest that the success of a
genotype does not always reflect its viral fitness [7]. In fact, we
have shown that novel genotypes, especially those that arise during
large epidemic outbreaks, can face high risks of extinction despite
possessing a fitness advantage. Furthermore, even successful
genotypes, i.e. those that eventually reach fixation, potentially
undergo prolonged periods of low frequency which can span for
Figure 6. The effect of transmission and serotype competition on invasion success. The success rate of the invading genotype, DENV29,
strongly varies depending on the number of total infected individuals and the relative prevalence of serotype 2 in the population at the time point of
introduction (TPI). (A) The invasion success (orange line) oscillates out of phase with total dengue incidence (grey line) and is minimized when disease
prevalence peaks, demonstrating how the current level of transmission can influence the invasion success of new advantageous genotypes. (B) The
highest rates of successful invasions can be observed during periods of low relative prevalence of serotype 2 (blue line). In contrast, the probability of
an invading advantageous genotype to get established and reach fixation is significantly reduced as serotype 2 gains wide-spread dominant within
the population. Parameters as in Table 1 and rb~0:045.
doi:10.1371/journal.pntd.0000894.g006
Dengue Genotype Replacement
www.plosntds.org 9 November 2010 | Volume 4 | Issue 11 | e894
several transmission seasons independently of the epidemics
therein. Therefore, low measures of adaptive selection in this
case would not necessarily imply strong purifying selection
but could equally be explained by other epidemiological factors.
This, however, needs to be confirmed within a more rigorous
framework.
Dengue’s two-host life-cycle implies a significant evolutionary
constraint whereby the majority of newly arising variants are likely
to be deleterious and selectively removed from the population. We
have shown that even novel and advantageous DENV genotypes
can undergo periods of several years prior reaching sufficiently
large population sizes to escape the risk of extinction. Our results
thus indicate that in addition to purifying selection, the
epidemiological landscape and stochastic effects might be equally
important determinants in shaping the viral evolutionary ecology.
Supporting Information
Figure S1 Model behaviour under different levels of
enhancement. Under a wide range of parameter values, the
model reproduces the observed epidemiological pattern of dengue.
In agreement with previous models, the level of ADE, either in
terms of transmission or susceptibility enhancement (Q and c,
respectively), has a significant effect on the qualitative dynamics,
with greater degrees of ADE generally leading to more
pronounced epidemic outbreak and chaotic serotype oscillations.
These simulated time series show the cyclical behaviour in
serotype prevalence (coloured lines) and regular epidemic
outbreaks (grey) for (A) Q= c= 1.0 (B) Q= c= 1.3 (C) Q= 1.9
c= 1.3 (D) Q= 1.3 c= 1.9. Other parameter values as in Table 1
(main text).
Found at: doi:10.1371/journal.pntd.0000894.s001 (1.57 MB TIF)
Figure S2 Model behaviour under different levels of
temporary heterologous immunity. Under various periods
of temporary heterologous immunity (a), the model reproduces the
observed epidemiological pattern of dengue. Increasing the value
of a - (A) 3.5, (B) 4.5, (C) 5.5, (D) 6.5 - leads to higher
interepidemic periods as epidemics caused by one serotype build
temporary immunity and prevent DENV from exploring the
human population until immunity wanes.
Found at: doi:10.1371/journal.pntd.0000894.s002 (1.60 MB
TIF)
Figure S3 The effect of viral fitness assuming changes
in infectious period and secondary infections. The graph
demonstrates the increased rate in competitive exclusion of the
resident genotype DENV2 for increasing levels of viral fitness of
DENV29 expressed as (A) infectious period (rs) and (B) increased
infectivity in secondary infections (rW). (A) Similar fitness
differences are required for displacement to take place in the
same time window as in Figure 4, main text. (B) Higher fitness
differences are required for displacement to take place in the same
time window as in Figure 4, main text. Other parameter values as
in Table 1 (main text).
Found at: doi:10.1371/journal.pntd.0000894.s003 (0.45 MB TIF)
Figure S4 The synergistic effect of viral fitness assum-
ing changes in the extrinsic incubation period and
human-to-vector transmission. The graph demonstrates
the increased rate in competitive exclusion of the resident
genotype DENV2 for increasing levels of viral fitness of DENV29
expressed as a shorter extrinsic incubation period (rm) and
increased human-to-vector transmission (rb) (see Methods in main
text). (A,B) Equal fitness differences either expressed as shorter
extrinsic incubation period or increased human-to-vector trans-
mission lead to similar emergence and fixation times. (C) The
effect of rm and rb on the invasion dynamics is additive. Other
parameter values as in Table 1 (main text).
Found at: doi:10.1371/journal.pntd.0000894.s004 (1.19 MB TIF)
Figure S5 The effect of viral fitness assuming changes
extrinsic incubation period. The graph demonstrates the
increased rate in competitive exclusion of the resident genotype
DENV2 for increasing levels of viral fitness of DENV29 expressed
as a shorter extrinsic incubation period (rm) (see Methods). (A)
Higher fitness differences lead to shorter waiting and fixation
times. (B) Interestingly, even significant advantages, here rm= 0.2,
i.e. a 20% fitter genotype, does not result in severe disruption of
Figure 7. The effect of serotype competition on the emergence time of successful fixation events. The total time required for a novel
(and eventually successful) genotype DENV29 to reach detection level is highly dependent on the relative prevalence of serotype 2 at the time it
enters the population. The red crosses show how the average emergence times, i.e. the period between introduction and reaching a 10% detection
threshold, of successful invasion events increases with the relative prevalence of DENV2 at the time of introduction (blue line). Standard deviations,
based on 10 simulated successful invasion events, are shown as grey bars. Parameters as in Table 1 and rb~0:045.
doi:10.1371/journal.pntd.0000894.g007
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the incidence patterns of dengue. Other parameter values as in
Table 1 (main text).
Found at: doi:10.1371/journal.pntd.0000894.s005 (1.21 MB TIF)
Figure S6 Effects of other population status on total
time of fixation. The graphs show the time taken for a novel
serotype 2 genotype to reach fixation given (A) the number of
susceptible (naı¨ve) individuals, (B) dengue disease prevalence, (C)
number of susceptible individuals to serotype 2 and (D) seasonality,
at the time point of introduction of the invading genotype (black
curves). Points represent an introduction event, given a certain
population status, and are coloured according to the total time for
fixation. A clear increase in total time is observed in all 4 plots
along the chosen time window with no correlation between any of
the variables in A,B,C or D. rb= 0.045 all other parameter values
as in Table 1 (main text).
Found at: doi:10.1371/journal.pntd.0000894.s006 (1.16 MB TIF)
Figure S7 Stochastic model behaviour. Initialized with the
population state and parameters of the deterministic model at
t = 1250, the stochastic model exhibits a similar time series as
presented in Figure 2 (main text) with persistence of all serotypes.
This simulated time series show the cyclical behaviour in serotype
prevalence (coloured lines) and regular epidemic outbreaks (grey).
Parameter values as in Table 1 (main text).
Found at: doi:10.1371/journal.pntd.0000894.s007 (0.96 MB TIF)
Figure S8 Effect of fitness advantage on invasion
success. Considering a fixed time point for introduction,
increasing values of rb result in higher invasion success rates of
DENV29 and lowers fixation time. Time of introduction 1259.5,
parameter values as in Table 1 (main text).
Found at: doi:10.1371/journal.pntd.0000894.s008 (0.29 MB TIF)
Figure S9 The effect of transmission and serotype
competition on invasion success and emergence time
of successful fixation events, assuming changes in the
EIP. The success rate of the invading genotype, DENV29,
strongly varies depending on the number of total infected
individuals and the relative prevalence of serotype 2 in the
population at the time point of introduction (TPI). The total time
required for a novel (and eventually successful) genotype DENV29
to reach detection level is highly dependent on the relative
prevalence of serotype 2 at the time it enters the population. (A)
The invasion success (orange line) oscillates out of phase with total
dengue incidence (grey line) and is minimized when disease
prevalence peaks, demonstrating how the current level of
transmission can influence the invasion success of new advanta-
geous genotypes. (B) The highest rates of successful invasions can
be observed during periods of low relative prevalence of serotype 2
(blue line). In contrast, the probability of an invading advanta-
geous genotype to get established and reach fixation is significantly
reduced as serotype 2 gains wide-spread dominant within the
population. (C) The red points show how the average emergence
times, i.e. the period between introduction and reaching a 10%
detection threshold, of successful invasion events increases with the
relative prevalence of DENV2 at the time of introduction (blue
line). Standard deviations, based on 10 simulated successful
invasion events, are shown as light-blue bars. Parameters as in
Table 1 and rm= 0.045 for S9.
Found at: doi:10.1371/journal.pntd.0000894.s009 (1.22 MB TIF)
Figure S10 The effect of transmission and serotype
competition on invasion success and emergence time of
successful fixation events, assuming changes in human
infectious period. The success rate of the invading genotype,
DENV29, strongly varies depending on the number of total
infected individuals and the relative prevalence of serotype 2 in the
population at the time point of introduction (TPI). The total time
required for a novel (and eventually successful) genotype DENV29
to reach detection level is highly dependent on the relative
prevalence of serotype 2 at the time it enters the population. (A)
The invasion success (orange line) oscillates out of phase with total
dengue incidence (grey line) and is minimized when disease
prevalence peaks, demonstrating how the current level of
transmission can influence the invasion success of new advanta-
geous genotypes. (B) The highest rates of successful invasions can
be observed during periods of low relative prevalence of serotype 2
(blue line). In contrast, the probability of an invading advanta-
geous genotype to get established and reach fixation is significantly
reduced as serotype 2 gains wide-spread dominant within the
population. (C) The red points show how the average emergence
times, i.e. the period between introduction and reaching a 10%
detection threshold, of successful invasion events increases with the
relative prevalence of DENV2 at the time of introduction (blue
line). Standard deviations, based on 10 simulated successful
invasion events, are shown as light-blue bars. Parameters as in
Table 1 and rs= 0.045.
Found at: doi:10.1371/journal.pntd.0000894.s010 (1.23 MB
TIF)
Figure S11 The effect of transmission and serotype
competition on invasion success and emergence time of
successful fixation events, assuming changes in trans-
missibility of secondary infections. The success rate of the
invading genotype, DENV29, strongly varies depending on the
number of total infected individuals and the relative prevalence of
serotype 2 in the population at the time point of introduction
(TPI). The total time required for a novel (and eventually
successful) genotype DENV29 to reach detection level is highly
dependent on the relative prevalence of serotype 2 at the time it
enters the population. (A) The invasion success (orange line)
oscillates out of phase with total dengue incidence (grey line) and is
minimized when disease prevalence peaks, demonstrating how the
current level of transmission can influence the invasion success of
new advantageous genotypes. (B) The highest rates of successful
invasions can be observed during periods of low relative
prevalence of serotype 2 (blue line). In contrast, the probability
of an invading advantageous genotype to get established and reach
fixation is significantly reduced as serotype 2 gains wide-spread
dominant within the population. (C) The red points show how the
average emergence times, i.e. the period between introduction and
reaching a 10% detection threshold, of successful invasion events
increases with the relative prevalence of DENV2 at the time of
introduction (blue line). Standard deviations, based on 10
simulated successful invasion events, are shown as light-blue bars.
Parameters as in Table 1 and rW= 0.075.
Found at: doi:10.1371/journal.pntd.0000894.s011 (1.20 MB TIF)
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